Thoracoabdominal Asynchrony and Respiratory Distress
Recruiting
N/A
Interventional Study
Respiratory Insufficiency
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 28 Days – 17
- Sex
- Any
- Study type
- Interventional
- Purpose
- Device Feasibility
- Participants needed
- 20 (estimated)
- Sponsor
- Massachusetts General Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The investigators hypothesize that a simple 3-point tracking device that uses motion sensors attached to the abdomen and chest of a child will provide information regarding thoracoabdominal asynchrony (TAA), a major component of respiratory distress, and ultimately help guide a clinician to initiate, escalate, de-escalate, or stop respiratory support interventions.
AIMS To determine if the TAA-mo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. patients 28-days to 17-years of age
2. who have respiratory distress and those who do not have respiratory distress
Exclusion Criteria:
Hardware, clinical care, or dermal injury that would preclude the application of TAA device
Contacts